CAS 1315350-19-6

1315350-19-6 6-(Cyclohexylamino)pyridine-2-boronic acid pinacol ester N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine cyclohexyl-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]amine

纯度 97%+现货药物标准品
CAS 号1315350-19-6
分子式C17H27BN2O2
分子量302.22 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

1315350-19-6 6-(Cyclohexylamino)pyridine-2-boronic acid pinacol ester N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine cyclohexyl-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]amine CAS 1315350-19-6 结构式 Chemical Structure

产品介绍 Description

（1315350-19-6 6-(Cyclohexylamino)pyridine-2-boronic acid pinacol ester N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine cyclohexyl-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]amine，CAS 号 1315350-19-6）是 CATO 佳途自主生产的药物标准品，分子式 C17H27BN2O2，分子量 302.22。纯度 97%+。本品采用严格的质量控制体系生产，附 COA 证书，适用于药物研发、质量控制和法规申报等场景。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括在内的目标物的控制。 化学式为 C17H27BN2O2 的（1315350-19-6 6-(Cyclohexylamino)pyridine-2-boronic acid pinacol ester N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridylamine），其CAS登记号是 1315350-19-6，分子量为 302.22 g/mol。 受分子结构中甾体骨架，酰胺类，含羟基，含醚键的影响，表现为类白色至淡黄色结晶性粉末。其固体形态的物理化学属性——包括302.22 g/mol的分子量——对于选择合适的样品前处理方法和分析技术具有指

应用场景：针对化学分析用途，（1315350-19-6 6-(Cyclohexylamino)pyridine-2-boronic acid pinacol ester N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine cyclohexyl- 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridy

理化性质 Physical & Chemical Properties

中文名称
分子式C17H27BN2O2
分子量302.22 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）5.5
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1990年
含氮原子数2

相关专利 Related Patents

  1. 发明人孙丽萍，林芳，冯建国. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 115972388 B, 授权公告日 2016-04-14.
  2. 发明人胡光，沈红梅，高志强. "Method for the Synthesis of 1315350-19-6 6-(Cyclohexylamino)pyridine-2-boronic acid pinacol ester N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine cyclohexyl-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]amine" [P]. 中国发明专利, 专利号 CN 108497839 B, 授权公告日 2024-12-06.

参考文献 Literature

  1. O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2017, 2131, (1), 3987-4011.
  2. Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2021, 1508, (8), 9046-9076.
  3. Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 1315350-19-6 6-(Cyclohexylamino)pyridine-2-boronic acid pinacol ester N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine N-cyclohexyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine cyclohexyl-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]amine Using HRMS and NMR". Chromatographia, 2017, 1174, (5), 1217-1232.
  4. O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2022, 500, (2), 1290-1295.

Related Cyclohexylamino Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...